USPTO serial 79363461
RANDOX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 17, 2025
- Examiner
- LADNER, CHRISOPHER G
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with RANDOX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Daniel D. Frohling
Daniel D. Frohling Loeb & Loeb LLP321 North Clark Street, Suite 2300Chicago, IL 60654United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry, science and photography, chemicals for use in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticide; diagnostic preparations for scientific purposes; chemical reagents for non-medical purposes, namely, for use in evaluating disease states in vitro for laboratory research purposes; diagnostic preparations for analysis of food products and water for scientific or research use; diagnostic reagents and preparations, except for medical or veterinary use, namely, diagnostic scanning agents for scientific use; diagnostic preparations for scientific or research use other than for medical use, namely, diagnostic testing materials; parts and fittings for all the aforesaid goods | ACTIVE | — |
| 005 | Pharmaceutical preparations and substances for use in medical clinical analysis and testing in connection with diagnosing cardiovascular diseases, coronary heart disease, brain diseases, cancer, diabetes, kidney diseases, renal diseases, anemia, dementia, nervous system dysfunctions, diseases of the central nervous system, autoimmune diseases, allergy, vascular diseases, infertility, menopause, early or delayed puberty, reproductive or non-reproductive disorders, gastrointestinal disorders, digestive diseases and conditions, metabolic diseases, hypercalcemia, thyroid diseases, bone disorders, respiratory diseases, infectious diseases, sexually transmitted diseases, and urinary tract infections, testing high or low levels of testosterone, testing for calcium absorption, testing of blood levels, antimicrobial testing, and screening for drug use; veterinary preparations and substances for testing of honey, egg, tissue, urine, feed and milk; Sanitary preparations and substances, namely, sterilizing preparations and disinfectants; blood serums and antitoxic sera for medical purposes; antitoxic sera; diagnostic preparations for medical and veterinary purposes; diagnostic preparations and substances for medical and veterinary purposes; diagnostic kits comprised of medical diagnostic reagents for testing of bodily fluids for use in disease states detection, namely, cardiac, stroke, metabolic, cancer, diabetes, fertility, thyroid and DNA arrays; clinical diagnostic preparations for medical or veterinary use; chemical diagnostic reagents for medical purposes, namely, clinical diagnostic reagents for in vitro and/or vivo use; diagnostic scanning agents for medical use, namely, diagnostic scanning agents for in vivo use; diagnostic testing materials for medical and veterinary use, namely, reagents for use in medical genetic testing and veterinary genetic testing; clinical medical reagents; reagents for use in diagnostic tests for medical and veterinary purposes; reagents for use with analyzers for medical and veterinary purposes; structural parts and fittings for all the aforesaid; clinical diagnostic preparations for medical purposes; enzymes for medical purposes | ACTIVE | — |
| 009 | Scientific and optical apparatus and instruments, namely, a benchtop analytical system composed of barcode scanner and associated software for reading barcodes, a chemiluminescent detection system in the nature of instruments for measuring chemiluminescence, a temperature controlled incubator for laboratory use, and an electronic reagent and patient sample dispenser, suitable for protein and DNA arrays for or relating to the analysis, monitoring, research and/or reporting of clinical data, for use in vitro diagnostic testing procedures for clinical, veterinary, food and toxicological analysis; data processing equipment and computers; downloadable computer software and computer programs for use in conjunction with in vitro diagnostic testing apparatus, namely, software for controlling medical and clinical sample processing, sample result reporting and test apparatus system robotics; downloadable computer software and computer programs for use in providing analysis, monitoring, research and reporting of clinical data; electronic database in the field of analysis, monitoring, research and reporting of clinical data, recorded on computer media; computer hardware and computer systems comprised primarily of computer hardware and also including recorded computer software for use in providing analysis, monitoring, research and reporting of clinical data; downloadable electronic publications, namely, books, blogs, articles, newsletters in the field of analysis, monitoring, research and reporting of clinical data scientific apparatus and instruments for scientific use relating to the analysis, monitoring, research and reporting of clinical data; optical apparatus and instruments, namely, optical sensors relating to the analysis, monitoring, research and reporting of clinical data; electronic diagnostic imaging apparatus, other than for medical use, for the study of chemical compounds and structures; clinical laboratory analytical instruments for the testing of clinical chemistry, toxicology, food and wine, other than for medical use; downloadable electronic publications in the nature of books, blogs, articles, newsletters in the field of diagnostics; structural parts and fittings for all the aforesaid goods | ACTIVE | — |
| 010 | clinical laboratory analytical instruments for medical diagnostic and treatment and veterinary purposes, namely, x-ray diagnostic apparatus, ultrasound diagnostic apparatus, probes for use in in vitro diagnostic testing procedures, clinical chemistry analyzers, blood testing apparatus, diagnostic saliva vials; clinical laboratory analytical instruments for medical diagnostic and treatment purposes, namely, x-ray diagnostic apparatus, ultrasound diagnostic apparatus, probes for use in in vitro diagnostic testing procedures, clinical chemistry analyzers, blood testing apparatus, diagnostic saliva vials | ACTIVE | — |
| 041 | Educational services, namely, conducting programs in the field of scientific research and diagnostics; providing training in the field of scientific research and diagnostics; planning, arranging and conducting courses, conferences, lectures, seminars, presentations, teach-in lectures, events, workshops and symposiums in the medical and healthcare fields; providing continuing medical education courses; organization of courses in the field of scientific research and diagnostics using distance learning methods; providing on-line courses of instruction in the field of scientific research and diagnostics being a type of instruction and training provided on-line from a computer database or from facilities provided on the Internet and other similar information networks; providing on-line tutorial videos in the field of scientific research and diagnostics, not downloadable; publishing of books, reviews, articles, magazines in the field of scientific research and diagnostics; advice, information and consultancy services for all of the aforesaid services | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific and technological analysis in the field of medicine and diagnostics and research and design relating thereto; design and development of computer hardware and software; medical research services; clinical research in the field of diagnostics; medical research, namely, analysis of human serum for medical research; medical research, namely, analysis of human tissue for medical research; chemical laboratory services; chemical analysis; chemical research; scientific laboratory services for analytical testing; medical laboratory services; biochemistry research; technology advisory services related to biochemistry research; biological research; technology advisory services related to biological research; computer programming in the medical field; design of medical apparatus; blood analysis services; development of test equipment for medical apparatus; research and development services relating to surgical and medical apparatus and instruments; providing quality assessment services being quality assurance services for clinical laboratories in the field of biochemistry; information, consultancy and advice relating to any of the aforesaid services | ACTIVE | — |
| 044 | Medical services; hygienic and beauty care for human beings; consultancy services relating to health care; health advice and information services; medical care services; health clinic services; health care services; medical consultations and lifestyle consultations, namely, professional medical consultations to individuals to assess their personal health and well-being; medical health assessment services; health screening services in the field of general health, immunology, nutrition, cardiac diseases, metabolism, cancer, diabetes, fertility, thyroid function; diagnostic health screening services in the field of general health, immunology, nutrition, cardiac diseases, metabolism, cancer, diabetes, fertility, thyroid function; medical reporting services, namely, preparation of reports relating to health care matters; professional consultancy relating to health; medical testing for diagnostic or treatment purposes in the field of general health, immunology, nutrition, cardiac diseases, metabolism, cancer, diabetes, fertility, thyroid function; medical diagnostic testing; nursing services; nursing care services; health assessment services, namely, medical health and fitness assessment services; providing medical consultancy and advisory services relating to immunology; consultancy and advisory services relating to nutrition; medical testing for diagnostic or treatment purposes in the field of cholesterol; genetic testing for medical purposes; providing hearing testing services; medical testing of blood; medical testing for diagnostic or treatment purposes of medical serums; medical testing of urine; medical testing for diagnostic or treatment purposes of bone functions; medical diagnostic testing services for the testing of major body organs, namely, heart, brain, lungs, kidneys, liver; medical diagnostic testing services for the testing of fertility hormone levels; health screening for pregnant women; pregnancy testing; health care services, namely, prenatal care services; postnatal care services, in the nature of deficiency diagnostics and personalised health plans; medical diagnostic testing services for the testing of diabetes; medical diagnostic testing services for the testing of thyroid function; medical diagnostic testing services, namely, medical testing of iron levels; medical assistance; medical clinics; advice, information and consultancy services for all of the aforesaid services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Randox Laboratories Limited
- Other trademarks owned by Randox Laboratories Limited
- Other trademarks owned by Randox Laboratories Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named RANDOX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 29, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 13, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 13, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 17, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 17, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 17, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 29, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 29, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 23, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 1, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 1, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 1, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 1, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 1, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 7, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 7, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 7, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 11, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 22, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 21, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 5, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 5, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 5, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 21, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| Oct 24, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 24, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 24, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 19, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 19, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 19, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 19, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 5, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| Jun 14, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 12, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 2, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 1, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 18, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 28, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 24, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 23, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |